57
Views
1
CrossRef citations to date
0
Altmetric
Commentary

Caring for the terminally ill patient with hematologic malignancies

Pages 313-314 | Published online: 01 Jul 2009

References

  • Appleby J, USA Today, 10/19/06. 2006
  • Abdel-Karim I A, Sammel R B, Prange M A. Causes of death at autopsy in an inpatient hospice program. J Palliat Med 2007; 10: 894–898
  • Salacz M E, Lankiewicz M W, Weissman D E. Management of thrombocytopenia in bone marrow failure: a review. J Palliat Med 2007; 10: 236–244
  • Gupta P, LeRoy S C, Luikart S D, Bateman A, Morrison V A. Long-term blood product transfusion support for patients with myelodysplastic syndromes (MDS): cost analysis and complications. Leuk Res 1999; 23: 953–959
  • British Committee for Standards in Haematology, Blood Transfusion Task Force. Guidelines for the use of platelet transfusions. Br J Haematol 2003; 122: 10–23
  • Gonzalez-Duarte A, Garcia-Ramos G S, Valdes-Ferrer S I, Cantu-Brito C. Clinical description of intracranial hemorrhage associated with bleeding disorders. J Stroke Cerebrovasc Dis 2008; 17: 204–207
  • Bick R L. Coagulation abnormalities in malignancy: a review. Semin Thromb Hemost 1992; 18: 353–372
  • Cartoni C, Niscola P, Breccia M, Brunetti G, D'Elia G M, Giovannini M, et al. Hemorrhagic complications in patients with advanced hematological malignancies followed at home: an Italian experience. Leuk Lymphoma 2009; 50: 387–391

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.